Skip to main content
. 2017 Dec;7(Suppl 3):S207–S218. doi: 10.21037/cdt.2017.09.12

Table 2. Statin and VTE related studies 2013–2016.

Year Title Patients Statin Statin use outcome
2016 Effects of rosuvastatin as an adjuvant treatment for deep vein thrombosis 234 Rosuvastatin Decreased CRP levels and decreased PTS incidence
2016 The association of statin therapy with the risk of recurrent venous thrombosis 2,798 Multiple Decreased recurrent VTE by 26%
2016 Platelet reactivity in patients with venous thrombosis who use rosuvastatin: a randomized controlled clinical trial 50 Rosuvastatin No effect on platelet reactivity
2016 Use of statins and reduced risk of recurrence of VTE in an older population. A population-based cohort study 25,681 Multiple Decreased recurrent VTE by 26%
2015 Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study 2,878 Multiple Lipid lowering therapy (statin + non-statin) decreased VTE
2015 Patterns, risk factors and treatment associated with PICC-DVT in hospitalized adults: A nested case-control study 909 Multiple Decreased PICC associated DVT
2014 Concurrent use of statins and hormone therapy and risk of venous thromboembolism in postmenopausal women: a population-based case-control study 955,582 Multiple Decreased VTE regardless of hormone therapy
2014 Perioperative pleiotropic statin effects in general surgery 7,777 Multiple Decreased perioperative VTE
2014 The association of statin use with reduced incidence of venous thromboembolism: a population-based cohort study 8,082 Multiple Decreased VTE with relative risk of 0.60
2014 Statins are associated with low risk of venous thromboembolism in patients with cancer: a prospective and observational cohort study 1,434 Multiple Decreased VTE in cancer patients
2014 Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study 27,862 Multiple Decreased recurrent VTE; high potency with more effect
2014 Statins, aspirin and risk of venous thromboembolic events in breast cancer patients 3,585 Multiple No change in VTE in breast cancer patients
2014 Statins, aspirin and risk of thromboembolic events in ovarian cancer patients 1,746 Multiple No change in VTE in ovarian cancer patients
2014 Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy 9,468 Multiple Decreased VTE by 24%
2013 The association between statin therapy during intensive care unit stay and the incidence of venous thromboembolism: a propensity score-adjusted analysis 798 Multiple No change in VTE in ICU patients
2013 Statin treatment and the risk of recurrent pulmonary embolism 3,093 Multiple Decreased PE by 50%
2013 Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study 44,330 Multiple Decreased recurrent VTE by 26%

VTE, venous thromboembolism; CRP, C-reactive protein; PTS, post-thrombotic syndrome; PICC, peripherally inserted central catheter; DVT, deep venous thrombosis; PE, pulmonary embolism.